Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HIF1A | Q16665 | 1/20 | 1.00 |
| ▸ | HSPA8 | P11142 | 5/20 | 0.83 |
| ▸ | CDK2 | P24941 | 3/20 | 0.74 |
| ▸ | CDK1 | P06493 | 2/20 | 0.74 |
| ▸ | CCNA2 | P20248 | 2/20 | 0.74 |
| ▸ | CCNA1 | P78396 | 2/20 | 0.74 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.74 |
| ▸ | CDK5 | Q00535 | 2/20 | 0.57 |
| ▸ | CDK5R1 | Q15078 | 1/20 | 0.57 |
| ▸ | HSPA5 | P11021 | 2/20 | 0.53 |
| ▸ | ADK | P55263 | 4/20 | 0.52 |
| ▸ | DOT1L | Q8TEK3 | 3/20 | 0.52 |
| ▸ | DCLK1 | O15075 | 1/20 | 0.52 |
| ▸ | DAPK3 | O43293 | 1/20 | 0.52 |
| ▸ | DYRK3 | O43781 | 1/20 | 0.52 |
| ▸ | ROS1 | P08922 | 1/20 | 0.52 |
| ▸ | RPS6KB1 | P23443 | 1/20 | 0.52 |
| ▸ | FLT3 | P36888 | 1/20 | 0.52 |
| ▸ | CSNK1A1 | P48729 | 1/20 | 0.52 |
| ▸ | CSNK1D | P48730 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12284814 | 1.00 | HIF1A (1.00) | HIF1AHSPA8CDK2CDK1CCNA2 | |
| SCHEMBL29780006 | 1.00 | HIF1A (1.00) | HIF1AHSPA8CDK2CDK1CCNA2 | |
| SCHEMBL2384313 | 1.00 | HIF1A (1.00) | HIF1AHSPA8CDK2CDK1CCNA2 | |
| SCHEMBL20141370 | 0.90 | HIF1A (0.81) | HIF1AHSPA8CDK2CDK1CCNA2 | |
| SCHEMBL22111064 | 0.90 | HIF1A (0.81) | HIF1AHSPA8CDK2CDK1CCNA2 | |
| SCHEMBL20141362 | 0.88 | HIF1A (0.79) | HIF1AHSPA8CDK2CDK1CCNA2 | |
| SCHEMBL22111053 | 0.87 | HIF1A (0.77) | HIF1AHSPA8CDK2CDK1CCNA2 | |
| SCHEMBL30131081 | 0.87 | HIF1A (0.77) | HIF1AHSPA8CDK2CDK1CCNA2 | |
| SCHEMBL20141988 | 0.87 | HIF1A (0.77) | HIF1AHSPA8CDK2CDK1CCNA2 | |
| SCHEMBL20141359 | 0.86 | HIF1A (0.75) | HIF1AHSPA8CDK2CDK1CCNA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2214670-A2 | COMPOUNDS FOR TREATING ABNORMAL CELLULAR PROLIFERATION | Taiga Biotechnologies, Inc. (US) | 2010-08-11 | — | — | EP | claimed |
| WO-2009059304-A2 | COMPOUNDS FOR TREATING ABNORMAL CELLULAR PROLIFERATION | TAIGA BIOTECHNOLOGIES, INC. (US) | 2009-05-07 | — | — | WO | claimed |
| US-20240052418-A1 | METHOD FOR PREDICTING A SUBJECT'S RESPONSE TO SLC MODULATOR THERAPY | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2024-02-15 | — | — | US | disclosed |
| US-11814681-B2 | Method for predicting a subjects response to SLC modulator therapy | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2023-11-14 | — | — | US | disclosed |
| US-20210254158-A1 | METHOD FOR PREDICTING A SUBJECTS RESPONSE TO SLC MODULATOR THERAPY | RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC. | 2021-08-19 | — | — | US | disclosed |
| EP-3207048-A1 | COMPOSITIONS AND METHODS OF TREATING MUSCULAR DYSTROPHY | The Broad Institute, Inc. (US) | 2017-08-23 | — | — | EP | disclosed |
| US-20170224758-A1 | COMPOSITIONS AND METHODS OF TREATING MUSCULAR DYSTROPHY | THE BROAD INSTITUTE, INC. (US) | 2017-08-10 | — | — | US | disclosed |
| WO-2016061509-A1 | COMPOSITIONS AND METHODS OF TREATNG MUSCULAR DYSTROPHY | THE BROAD INSTITUTE, INC. (US) | 2016-04-21 | — | — | WO | disclosed |
| US-8207136-B2 | Nucleoside compounds and methods of use thereof | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2012-06-26 | — | — | US | disclosed |
| US-8207136-B2 | Nucleoside compounds and methods of use thereof | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2012-06-26 | — | — | US | disclosed |
| US-8207136-B2 | Nucleoside compounds and methods of use thereof | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2012-06-26 | — | — | US | disclosed |
| EP-2214670-A2 | COMPOUNDS FOR TREATING ABNORMAL CELLULAR PROLIFERATION | Taiga Biotechnologies, Inc. (US) | 2010-08-11 | — | — | EP | disclosed |
| US-20090117651-A1 | Nucleoside compounds and methods of use thereof | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS | 2009-05-07 | — | — | US | disclosed |
| US-20090117651-A1 | Nucleoside compounds and methods of use thereof | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS | 2009-05-07 | — | — | US | disclosed |
| US-20090117651-A1 | Nucleoside compounds and methods of use thereof | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS | 2009-05-07 | — | — | US | disclosed |
| WO-2009059304-A2 | COMPOUNDS FOR TREATING ABNORMAL CELLULAR PROLIFERATION | TAIGA BIOTECHNOLOGIES, INC. (US) | 2009-05-07 | — | — | WO | disclosed |
| EP-1876894-A1 | NUCLEOSIDE COMPOUNDS AND METHODS OF USE THEREOF | The Board of Trustees of the University of Illinois (US) | 2008-01-16 | — | — | EP | disclosed |
| EP-1876894-A1 | NUCLEOSIDE COMPOUNDS AND METHODS OF USE THEREOF | The Board of Trustees of the University of Illinois (US) | 2008-01-16 | — | — | EP | disclosed |
| WO-2006116512-A1 | NUCLEOSIDE COMPOUNDS AND METHODS OF USE THEREOF | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS, URBANA, IL (US) | 2006-11-02 | — | — | WO | disclosed |
| WO-2006116512-A1 | NUCLEOSIDE COMPOUNDS AND METHODS OF USE THEREOF | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS, URBANA, IL (US) | 2006-11-02 | — | — | WO | disclosed |